Quantum biopharma reports strong second quarter with increased current and total assets, conversion of all debentures into equity, continued exclusion of going concern, tripling of share price during quarter, over $500,000 usd gain in crypto assets as of date of filing, and near elimination of debt

Unprecedented quarter shows company's strong financial position and continued momentum with its multiple sclerosis clinical trials and unbuzzdtm recreational beverage and alcohol metabolizer unprecedented quarter shows company's strong financial position and continued momentum with its multiple sclerosis clinical trials and unbuzzdtm recreational beverage and alcohol metabolizer
QNTM Ratings Summary
QNTM Quant Ranking